Indica Labs Reports 260% Clinical Revenue Growth and Expansion into New Global Markets
recent articles
Albuquerque, NM, December 17, 2025 – Indica Labs, the global leader in AI-powered digital pathology, announced today that clinical revenue for HALO AP® is up 260% since 2023 and recurring revenue for 2025 shows a 200% increase...
Aiforia expands its AI technology platform featuring the powerful Vision Transformer architecture and proprietary Foundation Engine. Aiforia Technologies Plc, Press Release, December 17, 2025 at 9:00 a.m. EET Aiforia Technologies Plc...
Collaboration to leverage Lunit SCOPE IO ® and SCOPE universal IHC® (uIHC) digital pathology products in two Daiichi Sankyo oncology research and development programs SEOUL, South Korea, Dec. 15, 2025 /PRNewswire/ -- Lunit (KRX:328130),...
From Indica Labs: Spatial analysis of the tumor microenvironment provides critical insight into how cancer, immune, and stromal cells interact, helping researchers better understand disease behavior and therapeutic response. Indica Labs’...
The latest from the blog at Indica Labs As scientists work to continue unraveling the structural, cellular, and molecular complexities of the brain and its diseases, the characteristics of this unique tissue pose significant challenges...
Mindpeak: Patent covers novel approach for training AI systems and classifying cells in oncologic histopathological tissue diagnostics Hamburg, Germany – 10 December 2025 – Mindpeak, a global pioneer in AI-powered pathology solutions,...
